Literature DB >> 35864245

The systemic effect of type 1 interferon responsiveness on tumor immunotherapy.

Shicheng Su1,2, Erwei Song3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35864245     DOI: 10.1038/s41590-022-01275-2

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   31.250


× No keyword cloud information.
  1 in total

1.  Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.

Authors:  Giselle M Boukhaled; Ramy Gadalla; Heidi J Elsaesser; Diala Abd-Rabbo; Rene Quevedo; S Y Cindy Yang; Mengdi Guo; Ben X Wang; Babak Noamani; Diana Gray; Sally C M Lau; Kirsty Taylor; Kyaw Aung; Anna Spreafico; Aaron R Hansen; Samuel D Saibil; Naoto Hirano; Cynthia Guidos; Trevor J Pugh; Tracy L McGaha; Pamela S Ohashi; Adrian G Sacher; Marcus O Butler; David G Brooks
Journal:  Nat Immunol       Date:  2022-07-14       Impact factor: 31.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.